Section A – KMP Resignation Details

  • Name of Resigning KMP: M/s. B S R & Co. LLP
  • Designation: Statutory Auditors
  • Reason for Resignation: Management intends to align auditors with the auditors of Syngene International Limited (the holding company) due to mandatory rotation of the firm as auditors of the holding company under the Companies Act, 2013
  • Effective Date of Resignation: Immediate effect [July 7, 2026]
  • Date of Resignation Letter: July 7, 2026
  • Duration in Role: Appointed on July 21, 2023, scheduled to hold office until conclusion of the 6th Annual General Meeting after financial year ending March 31, 2028
  • Board's Acknowledgment / Statement: Not Specified
  • Replacement Appointed: Not Specified
  • Regulatory Compliance Statement: Disclosure made pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026
  • Delay in Disclosure: Not Specified

Analytical Add-On: The resignation appears strategic and planned, driven by mandatory auditor rotation requirements at the parent company level rather than performance or regulatory concerns. The auditor has completed the statutory audit for the most recent financial period (until March 31, 2026) and issued a clean report, suggesting no immediate impact on financial reporting integrity.

Section B – Additional Observations or Disclosures

  • Transition & Internal Role Reallocations: The auditor has completed statutory audit until March 31, 2026 and issued their audit report on April 28, 2026. No transition plan specified for future audits.
  • Successor Appointments: Not Specified

Section C – Financial & Governance Disclosures

  • Audited Financial Results: Not Specified
  • Auditor's Report Summary: The auditor completed statutory audit until March 31, 2026 and issued audit report on April 28, 2026. The annexure confirms no concerns were raised regarding inability to obtain sufficient audit evidence, management-imposed limitations, or significant impact on financial statements.
  • Dividends / Capital Changes / Buybacks: Not Specified
  • Board / Committee Updates or Key Appointments: Not Specified